FDA Calendar for Questcor Pharmaceuticals, Inc. (QCOR)

| Register (free)
Questcor Pharmaceuticals, Inc. (Questcor) markets H.P. Acthar Gel (repository corticotropin injection), an injectable drug that is approved for the treatment of certain disorders with an inflammatory component, including the treatment of exacerbations associated with multiple sclerosis (MS), and the treatment of nephrotic syndrome. H.P. Acthar Gel (Acthar) is not indicated for, but is also used in treating patients with infantile spasms (IS). The Company also markets Doral (quazepam), which is indicated for the treatment of insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings, and/or early morning awakenings. As of December 31, 2008, Acthar was approved in the United States for the treatment of exacerbations associated with MS, nephrotic syndrome and many other conditions with an inflammatory component.


Drug Pipeline

Drug NameType Of DrugFDA StatusDrug Phase
H.P. Acthar Other Pending DecisionNDA


Events

No future events listed at this time, please check back later.
3 past event(s) found. Click here to view them.

Add New Event

In order to write a comment you must first login.

Login or Register (for free!)

Add Event

QCOR

$36.61
1.525 +4.35%
2/3/2012 4:00:00 PM

Sponsors

Other Links